Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

Testing positive for COVID-19 is not exactly a positive experience ... Therefore, talk to a medical professional about whether you should get treatment and what kind. This should be a real ...

It also encourages the province to end the use of COVID vaccinations among healthy children and teenagers; conduct further ...

This update is based on a press release statement from Invivyd, Inc. The company's stock has experienced significant volatility, with a 16.39% gain in the past week despite a 64.17% decline over six ...

Hospital leaders expect case volume of flu, the common cold, and respiratory syncytial virus, RSV, to keep climbing.

Treatment options include oxygen therapy, intravenous fluids, and corticosteroids to address respiratory complications. In comparison, the cost of a COVID-19 RT-PCR test in India is significantly ...

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.

Seasonal influenza, respiratory syncytial virus (RSV), and COVID-19 are actively circulating throughout the United States.

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

OneBlood is the first blood center to get full FDA approval to give high-titer COVID-19 convalescent plasma to those with COVID-19 who are also immunocompromised.

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.